Benjamin R. Yerxa, EVP & Chf, Research & Develop at INSPIRE PHARMACEUTICALS INC (ISPH), sold 2,000 shares at $5.73 ($11K) on 2009-09-01, disclosed to the SEC on 2009-09-01.
Scheduled sale ($11k) by EVP & Chf, Research & Develop under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.62 | 48 | $270 | 2.4% |
| 2 | $5.67 | 1,000 | $6K | 49.9% |
| 3 | $5.68 | 552 | $3K | 27.6% |
| 4 | $5.69 | 100 | $569 | 5.0% |
| 5 | $5.70 | 137 | $781 | 6.9% |
| 6 | $5.71 | 100 |
| $571 |
| 5.0% |
| 7 | $5.73 | 63 | $361 | 3.2% |
| Total | $5.68 avg | 2,000 | $11K | 100% |
| Filing → |
| IRD | BUY | 2024-11-25 | $10K | — | Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |